InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-10.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by PATOU GARY, Director. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Aggregated, 8 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €355k. Activity tracked since 17 March 2021. The latest transaction was disclosed on 22 November 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
3,500 shares@ US$7.385.6% of flowCommon SharesSEC:0000950170-24-130378:0
6,378 shares@ US$9.8513.3% of flowCommon SharesSEC:0000950170-23-070841:0
7,598 shares@ US$41.0565.4% of flowCommon SharesSEC:0000950170-23-070912:0
2,057 shares@ US$34.326515.6% of flowCommon SharesSEC:0001209191-22-058916:0
2,057 shares@ US$3.670.0001% mcap40.2% of flowCommon SharesSEC:0001209191-21-069018:0
2,057 shares@ US$3.6740.2% of flowCommon SharesSEC:0001209191-21-069018
100 shares@ US$19.490.0000% mcap9.8% of flowCommon SharesSEC:0001209191-21-038431:0
100 shares@ US$19.499.8% of flowCommon SharesSEC:0001209191-21-038431
8 of 8 declarations
About PATOU GARY
Patou Gary is a Board Member at Xenon Pharmaceuticals Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and oversight of operations. His experience and expertise in the pharmaceutical sector are valuable assets for the company.
